Product Information

CEFPROZIL 250 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.4854 per EA under NDC 00093107701. Its NADAC has been published 665 times since Nov 28, 2013.

FDA first approved this application on Dec 6, 2005. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

CEFPROZIL 250 MG TABLET

Cefprozil
$0.4854per EA

Strength

250 mg/1

NDC

00093107701

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

CEFPROZIL

Approval Type

Generic (ANDA)

FDA Application

ANDA065208

FDA Approved

12/6/2005

TE Code

AB

On Market Since

12/23/2005

Price Statistics

The NADAC for CEFPROZIL 250 MG TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 59.7%. The table below summarizes its recorded NADAC range and movement.

Current price$0.4854 per EA
All-time high$1.5445 (Feb 12, 2014)
All-time low$0.4429 (Dec 21, 2022)
52-week high$0.5890
52-week low$0.4814
Median price$0.7394
Average price$0.7381
Largest weekly change+65.4% (Sep 22, 2021)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.7%

1M

+0.7%

3M

+0.5%

6M

-3.0%

1Y

-17.6%

3Y

-10.2%

5Y

-8.3%

All

-59.7%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of CEFPROZIL 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for CEFPROZIL 250 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.4854 per EA (NDC 00093107701), effective Aug 19, 2026.

How has the price of CEFPROZIL 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for CEFPROZIL 250 MG TABLET has declined 59.7%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CEFPROZIL 250 MG TABLET?

Since Nov 28, 2013, the NADAC for CEFPROZIL 250 MG TABLET has ranged from a low of $0.4429 (Dec 21, 2022) to a high of $1.5445 (Feb 12, 2014), with a median of $0.7394 per EA.

Are there cheaper alternatives to CEFPROZIL 250 MG TABLET?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CEFPROZIL 250 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures CEFPROZIL 250 MG TABLET?

CEFPROZIL 250 MG TABLET (NDC 00093107701) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.